Early research (Phase 1)Looking for participantsNCT05609994
What this trial is testing
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Who this might be right for
Low Grade Glioma of Brain
Katy Peters, MD, PhD 48